I recently interviewed a panel of our senior investment professionals to discuss the implications of President Trump's first 100 days in office, the impact of tariffs, and the resulting market volatility. The panelists included: Jennifer Johnston, Director of Research, Municipal Bonds, Franklin Templeton Fixed Income; Jeff Schulze, CFA, Head of Economic and Market Strategy, ClearBridge Investments; and Jonathan Curtis, Chief Investment Officer, Portfolio Manager, Franklin Equity Group. They provided insights into the resilience of the US economy, the challenges and opportunities in the tech sector, and the broader economic and market trends. This summary will delve into the key topics they analyzed.
Resilience of the US economy
In our panelists’ view, the US economy continues to be resilient. Despite recent challenges, the labor market remains healthy. The drop in initial jobless claims to 215,000 on April 17, 2025, is a historically low figure given the size of the labor force. This indicates that a significant portion of the workforce remains employed, and labor income, a crucial factor in consumption, remains strong. Additionally, while consumer confidence has declined, actual consumer spending has been broad-based and robust. This suggests to us that US consumers are in a good position to continue their consumption patterns.
Risks to US “exceptionalism”
A combination of factors led to a recent, simultaneous decline in US stock valuations, fixed income rates and the US dollar. Forced liquidations and a reversal of foreign investment in US assets have put pressure on Treasury yields and the US dollar. This de-risking follows years of overaccumulation of US assets. We also believe the US dollar has been overvalued for the past three to five years and we’ve expected some adjustment to it for quite a while. Additionally, the market had been reacting to the possibility of President Trump removing Federal Reserve (Fed) Chair Jerome Powell, which Trump later said was not his intention. Fed independence is viewed as crucial for US capital markets, and any threat to it could be highly disruptive.
If the US economy experiences stagflation, we believe value stocks would look favorable, as they have tended to perform well in higher-inflation and lower-growth environments. Historically, sectors like energy, materials and health care have also done well during stagflationary periods. Investing in commodities, precious metals (especially gold) and commodity-producing countries can provide additional diversification.
Trump’s next 100 days
In our opinion, the Trump administration has a high tolerance for equity market pain and is focused on resetting the economy, which includes bringing manufacturing back to the United States. It extended the tariff adoption by 90 days and is not providing many signals on negotiations. While the administration is less concerned about equity markets, it is closely monitoring the 10-year Treasury yield. This is because rates above 5% would make financing the government as well as capital investments in manufacturing more difficult. It's also worth remembering the forthcoming positive aspects for the United States economy of Trump’s agenda, such as deregulation and corporate tax cuts, especially incentives for capital investments.
Equity market outlook
We expect the S&P 500 Index is likely to be range-bound between recent lows and around 5400 in the short term, with a potential recession being the key risk factor. Historical data shows that market declines during recessions can be modest, and the current selloff has already reached those levels. Thus, we believe the market has priced in much of the negativity, which may present opportunities for long-term investors.
Impact of funding cuts on the health care sector
The Trump administration’s latest cuts to health care research funding are more severe than the initial reductions and could negatively impact the health care sector. We are concerned about who could step in to fill the gap, as venture capitalists are less likely to fund such speculative, early-stage research. Large endowments and foundations like the Gates Foundation might help, but the amounts needed are substantial. Despite the challenges, the sector remains defensive, with people continuing to need medical care and innovations—like genomics, biotech and artificial intelligence (AI)—reducing health care costs and improving productivity. In our analysis, this resilience and ongoing innovation presents potential opportunities for equity investors to find mispriced companies that can navigate the current uncertainty.
Impact of tariffs and regulatory actions on the technology sector
At the start of the year, there was high optimism in the tech sector. However, the introduction of tariffs (and subsequent pauses) have led to declining business sentiment and uncertainty in cost structures, especially for companies with supply chains in Asia. Ongoing legal cases against tech giants like Google have also contributed further to the uncertain environment. Despite these challenges, we believe a couple of growth themes remail largely intact. There is still significant investment in AI from major companies such as Google and Amazon. We believe the Magnificent Seven (Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla) remain strong in fundamentals and innovation. Additionally, there is continued demand for AI applications from firms. In our analysis, the productivity gains from AI will likely be profound, and the United States is the leader in this area.
Municipal bond market and local governments
Leading up to the US presidential election, there was a noticeable slowdown in municipal revenue growth. However, the municipal bond market has benefited significantly from the post-COVID stimulus and inflation, which have driven up sales and income taxes. These taxes are primary revenue sources for state and local governments, including transit districts, and have helped strengthen the credit spectrum for municipal bonds. Despite some sectors struggling more than others, the overall credit position for municipals looks strong, and the slower growth assumptions in fiscal year 2025 budgets are being outpaced. This robust positioning, combined with management policies that have been honed during challenging times, suggests to us that the market is well-prepared to weather a potential rise in inflation or a recession. Even with increased supply in the municipal market and some volatility, sectors across the board are ready to issue and build capital, though higher rates could slow this activity.
One sector of note is the education sector. The higher education market is divided, with strong institutions like Harvard and Stanford on one end and struggling small regional liberal arts schools on the other. Many private colleges have closed or merged over the past two years, an unprecedented trend. While concerns over funding for research grants at top institutions exist, we believe these schools are well-positioned to absorb such losses.
There has been some discussion of municipal bonds’ potential loss of their tax exemption, which could have far-reaching implications, including higher borrowing costs. However, the tax exemption for municipal bonds is crucial for funding infrastructure at a lower cost, and there is strong support in Congress to maintain it. While certain sectors like higher education, private-activity bonds and health care could be targeted, we think the overall municipal bond market is unlikely to lose its tax-exempt status.
We think there is more value in staying neutral on duration while adding value through credit risk, often by investing in longer maturities and lower-rated bonds. There are also opportunities to capitalize on retail investors’ panic during volatility, with opportunities across the yield curve, especially in high-grade bonds that have become cheaper.
Conclusion
Despite ongoing uncertainty and volatility in the equity and bond markets, we believe the current environment presents significant opportunities. The tech sector, particularly in AI, remains a strong area of growth, with US companies leading the way in innovation. We believe focusing on company fundamentals is crucial, as this approach can help navigate challenges and seek to take advantage of what we consider market mispricings.
WHAT ARE THE RISKS?
All investments involve risks, including possible loss of principal.
Equity securities are subject to price fluctuation and possible loss of principal.
Fixed income securities involve interest rate, credit, inflation and reinvestment risks, and possible loss of principal. As interest rates rise, the value of fixed income securities falls. Changes in the credit rating of a bond, or in the credit rating or financial strength of a bond’s issuer, insurer or guarantor, may affect the bond’s value. Low-rated, high-yield bonds are subject to greater price volatility, illiquidity and possibility of default. Alternative Minimum Tax, and state and local taxes may apply.
Investment strategies that incorporate the identification of thematic investment opportunities, and their performance, may be negatively impacted if the investment manager does not correctly identify such opportunities or if the theme develops in an unexpected manner. Focusing investments in health care-, technology- and information technology-related industries carries much greater risks of adverse developments and price movements in such industries than a strategy that invests in a wider variety of industries.
Commodity-related investments are subject to additional risks such as commodity index volatility, investor speculation, interest rates, weather, tax and regulatory developments.
Diversification does not guarantee a profit or protect against a loss.
Any companies and/or case studies referenced herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. The information provided is not a recommendation or individual investment advice for any particular security, strategy, or investment product and is not an indication of the trading intent of any Franklin Templeton managed portfolio.
WF: 4422415

